Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?What is the difference between apixaban and apixaban accord?Pramlintide fda approval date?How long have hydroxyzine pamoate been on the market?Prolia and osteonecrosis?
See the DrugPatentWatch profile for Sublocade
Sublocade (buprenorphine extended-release injection) received FDA approval on October 26, 2017 [1].
This date refers to when the FDA approved Sublocade for marketing, not when it first entered clinical practice or when later dosage forms/label updates were approved [1].
The source provided here gives the initial FDA approval date; it does not list subsequent approval dates for label supplements or new formulations. If you need a later timeline, you can use the same FDA-regulatory tracking approach tied to Sublocade’s approval history [1].
[1] https://www.drugs.com/history/sublocade.html
Other Questions About Sublocade :